Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Non-Current Assets (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Non-Current Assets for 15 consecutive years, with $39.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-Current Assets fell 29.62% year-over-year to $39.9 million, compared with a TTM value of $39.9 million through Sep 2025, down 29.62%, and an annual FY2024 reading of $54.8 million, changed 0.14% over the prior year.
  • Non-Current Assets was $39.9 million for Q3 2025 at Sanara MedTech, down from $65.1 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $65.1 million in Q2 2025 and bottomed at $7.5 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $38.6 million, with a median of $40.9 million recorded in 2022.
  • The sharpest move saw Non-Current Assets skyrocketed 282.34% in 2022, then dropped 29.62% in 2025.
  • Year by year, Non-Current Assets stood at $11.8 million in 2021, then skyrocketed by 242.88% to $40.4 million in 2022, then surged by 35.74% to $54.9 million in 2023, then dropped by 0.14% to $54.8 million in 2024, then decreased by 27.24% to $39.9 million in 2025.
  • Business Quant data shows Non-Current Assets for SMTI at $39.9 million in Q3 2025, $65.1 million in Q2 2025, and $59.5 million in Q1 2025.